MétaCan
← all works

ATR/CHK1 inhibitors and cancer therapy

2017· review· en· 388 citations· W2766300480 on OpenAlex· 10.1016/j.radonc.2017.09.043

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.046
GPT teacher head0.379
Teacher spread
0.333 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
Radiotherapy and Oncology
Topic
DNA Repair Mechanisms
Field
Biochemistry, Genetics and Molecular Biology
Canadian institutions
Funders
National Cancer InstituteSchool of Medicine, Case Western Reserve UniversitySchool of MedicineWestern UniversityCase Comprehensive Cancer Center, Case Western Reserve UniversityComprehensive Cancer Center, City of Hope
Keywords
CHEK1DNA damageSynthetic lethalityCancer researchDNA repairAtaxia-telangiectasiaCancer cellG2-M DNA damage checkpointMitosisCell cycle checkpointCell cycleCancerBiologyKinaseDNACell biologyGenetics
Has abstract in OpenAlex
no